Assignee
INHIBRX BIOSCIENCES INC
US·11 granted patents·18 pending applications·2 citations·filing 2019–2025
Top patents by PatentIndex Score
29 records- 0188US12043667B2CLEC12a binding polypeptides and uses thereofINHIBRX BIOSCIENCES INC·Filed 2020·Granted Jul 23, 2024·2 cites·27 claims
- 0286US12331126B2OX40-binding polypeptides and uses thereofINHIBRX BIOSCIENCES INC·Filed 2024·Granted Jun 17, 2025·0 cites·47 claims
- 0384US2025250349A1Uses of pdl1-binding proteinsINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0483US2024376220A1Multivalent and Multispecific DR5-Binding Fusion ProteinsINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0581US12297271B2PD-1 single domain antibodies and therapeutic compositions thereofINHIBRX BIOSCIENCES INC·Filed 2024·Granted May 13, 2025·0 cites·18 claims
- 0681US12187804B2Multivalent and multispecific 41BB-binding proteinsINHIBRX BIOSCIENCES INC·Filed 2022·Granted Jan 7, 2025·0 cites·12 claims
- 0781US2025223338A1Non-immunogenic single domain antibodiesINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0879US12331132B2Multispecific polypeptide constructs having constrained CD3 binding and related methods and usesINHIBRX BIOSCIENCES INC·Filed 2023·Granted Jun 17, 2025·0 cites·21 claims
- 0977US2026008860A1OX40-Binding Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1077US2025059279A1CD33-Binding Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1176US2025011436A1CLEC12a Binding Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1275US2025092137A1Multispecific polypeptide constructs containing a constrained cd3 binding domain and a receptor binding region and methods of using the sameINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1374US2025361319A1Multispecific polypeptide constructs having constrained cd3 binding and related methods and usesINHIBRX BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1473US12084502B2CD33-binding polypeptides and uses thereofINHIBRX BIOSCIENCES INC·Filed 2022·Granted Sep 10, 2024·0 cites·27 claims
- 1572US12227584B2Multivalent and multispecific OX40-binding fusion proteinsINHIBRX BIOSCIENCES INC·Filed 2021·Granted Feb 18, 2025·0 cites·18 claims
- 1663US2025313623A1Dll3 single domain antibodies and therapeutic compositions thereofINHIBRX BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1761US12365728B2DLL3 single domain antibodies and therapeutic compositions thereofINHIBRX BIOSCIENCES INC·Filed 2019·Granted Jul 22, 2025·0 cites·32 claims
- 1861US2025302948A1DR5 Agonist and IAP Antagonist Combination TherapyINHIBRX BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1961US2025353911A1FcRn-Binding Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2061US2025277018A1Albumin-Binding Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2161US2025215101A1DR5 Agonist and PLK1 Inhibitor or CDK Inhibitor Combination TherapyINHIBRX BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2259US12195533B2Multispecific polypeptide constructs containing a constrained CD3 binding domain and a receptor binding region and methods of using the sameINHIBRX BIOSCIENCES INC·Filed 2019·Granted Jan 14, 2025·0 cites·27 claims
- 2359US2025066477A1Gamma Delta T-Cell-Binding Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2459US2025109203A1Gamma Delta T-Cell-Targeted Modified IL-2 Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2558US2025320295A1CD8-Binding Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2658US2025136681A1NKp46-Binding Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2756US2025332098A1Formulations of DR5 Binding PolypeptidesINHIBRX BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2848US12522661B2CD28 single domain antibodies and multivalent and multispecific constructs thereofINHIBRX BIOSCIENCES INC·Filed 2021·Granted Jan 13, 2026·0 cites·32 claims
- 2946US12590169B25T4 single domain antibodies and therapeutic compositions thereofINHIBRX BIOSCIENCES INC·Filed 2019·Granted Mar 31, 2026·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when INHIBRX BIOSCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →